Skip to content
healthcare.dev

Nelarabine

NDC 70771-1685, Nelarabine, injection, from Zydus Lifesciences Limited.

Product NDC
70771-1685
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215037
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1685 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NELARABINE5 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
70771-1685-1707711685011 VIAL in 1 CARTON (70771-1685-1) / 50 mL in 1 VIAL
70771-1685-8707711685086 VIAL in 1 CARTON (70771-1685-8) / 50 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/877b69a0-0899-455d-926e-f5a7478c31f8

Use it

Look up 70771-1685 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1685 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1685. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.